Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer

US7705120B2 · kind B2 · utility

Assignees

• Millennium Pharmaceuticals, Inc. · US
• The Board of Regents of the University of Texas System · US

Inventors

• James Lillie · Wellesley, US
• Manjula Gannavarapu · Acton, US
• Karen Glatt · Natick, US
• Sebastian Hoersch · Arlington, US
• Shubhangi Kamatkar · Newton, US
• Maureen Mertens · Stow, US
• John E. Monahan · Walpole, US
• Vickesh Myer · Harvard, US
• Youzhen Wang · Newton, US
• Yongyao Xu · Belmont, US
• Xumei Zhao · Wayland, US
• Rachel Meyers · Newton, US
• Robert C. Bast, Jr. · Houston, US
• Gabriel N. Hortobagyi · Houston, US
• Lajos Pusztai · Bellaire, US

Key dates

• Filing date: Jun 21, 2002
• Grant date: Apr 27, 2010
• Expiry date: Aug 12, 2024

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q2600/158
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The invention relates to newly discovered nucleic acid molecules and proteins associated with breast cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers are provided.